Literature DB >> 11428918

Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools.

F J Sharom1, R Liu, Q Qu, Y Romsicki.   

Abstract

P-glycoprotein is an ABC protein that functions as an efflux pump for multiple drugs, natural products and peptides. It is proposed to operate as a hydrophobic vacuum cleaner, expelling non-polar compounds from the membrane bilayer to the exterior, driven by the energy of ATP hydrolysis. The nucleotide-binding domains of P-glycoprotein appear to operate by an alternating sites mechanism to power drug transport. In recent years, purification and functional reconstitution of the protein has allowed the application of fluorescence spectroscopic techniques. This approach has led to insights into the structural architecture of the P-glycoprotein molecule, and a more detailed understanding of the way in which it interacts with nucleotides and drugs. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11428918     DOI: 10.1006/scdb.2000.0251

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  20 in total

Review 1.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

2.  The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells.

Authors:  Thuy Thanh Tran; Aditya Mittal; Tanya Aldinger; Joseph W Polli; Andrew Ayrton; Harma Ellens; Joe Bentz
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

3.  Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporter.

Authors:  Paula L Russell; Frances J Sharom
Journal:  Biochem J       Date:  2006-10-15       Impact factor: 3.857

4.  Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities.

Authors:  Karsten Bucher; Camille A Besse; Sarah W Kamau; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

5.  Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.

Authors:  Dana Emmert; Christopher R Campos; David Ward; Peihua Lu; Hilda A Namanja; Kelsey Bohn; David S Miller; Frances J Sharom; Jean Chmielewski; Christine A Hrycyna
Journal:  ACS Chem Neurosci       Date:  2014-02-07       Impact factor: 4.418

6.  Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.

Authors:  Er-jia Wang; Christopher N Casciano; Robert P Clement; William W Johnson
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

7.  Benzodiazepine-mediated structural changes in the multidrug transporter P-glycoprotein: an intrinsic fluorescence quenching analysis.

Authors:  Sofia A C Lima; Anabela Cordeiro-da-Silva; Baltazar de Castro; Paula Gameiro
Journal:  J Membr Biol       Date:  2008-09-14       Impact factor: 1.843

8.  In vitro chemosensitivity testing of primary and recurrent breast carcinomas and its clinical significance.

Authors:  Zhi Li; Haiping Song; Wenshan He; Yuan Tian; Tao Huang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

9.  Imaging reversal of multidrug resistance in living mice with bioluminescence: MDR1 P-glycoprotein transports coelenterazine.

Authors:  Andrea Pichler; Julie L Prior; David Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-30       Impact factor: 11.205

10.  Quantitative fluorescence microscopy provides high resolution imaging of passive diffusion and P-gp mediated efflux at the in vivo blood-brain barrier.

Authors:  Rajendar K Mittapalli; Vamshi K Manda; Kaci A Bohn; Chris E Adkins; Paul R Lockman
Journal:  J Neurosci Methods       Date:  2013-08-02       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.